What is an Imatib 400 mg Tablet?

Imatib 400 mg is a prescription medication used in the treatment of certain types of blood cancers and related disorders. It contains Imatinib Mesylate, a targeted therapy medicine that works by blocking specific proteins responsible for the uncontrolled growth of abnormal cells.

Unlike traditional chemotherapy, Imatib 400 mg is classified as a tyrosine kinase inhibitor (TKI), a treatment approach designed to target cancer cells more precisely. It is commonly prescribed for conditions such as chronic myeloid leukemia (CML), Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), and certain gastrointestinal stromal tumors (GISTs).

Active Ingredient

Generic Name: Imatinib Mesylate

Strength: 400 mg

Drug Class: Tyrosine Kinase Inhibitor (TKI)

Dosage Form: Oral Tablet

Administration Route: Oral Use

How Imatib 400 mg Tablet Works

The growth of some cancer cells depends on abnormal proteins known as tyrosine kinases. Imatinib works by blocking the activity of these proteins, preventing cancer cells from receiving signals that promote growth and multiplication.

By interrupting these cellular pathways, the medication helps slow disease progression, reduce the number of abnormal cells, and support long-term disease management. This targeted mechanism allows treatment to focus on specific cancer-related abnormalities while minimizing damage to healthy cells.

Medical Uses of Imatib 400 mg Tablet

Healthcare providers may prescribe Imatib 400 mg for various conditions, including:

Chronic Myeloid Leukemia (CML)

One of the most common uses of Imatinib is the treatment of Philadelphia chromosome-positive chronic myeloid leukemia in both newly diagnosed and previously treated patients.

Acute Lymphoblastic Leukemia (ALL)

The medication may be used in certain patients with Philadelphia chromosome-positive acute lymphoblastic leukemia as part of a broader treatment plan.

Gastrointestinal Stromal Tumors (GIST)

Imatib 400 mg is often prescribed for patients with specific types of gastrointestinal stromal tumors that carry mutations responsive to Imatinib therapy.

Other Approved Conditions

Doctors may also recommend this medication for selected rare blood disorders and cancers where abnormal tyrosine kinase activity plays a role in disease development.

Key Features of Imatib 400 mg Tablet

Targeted Cancer Therapy

Designed to specifically block proteins involved in cancer cell growth rather than affecting all rapidly dividing cells.

Oral Treatment Option

Available in tablet form, making administration more convenient compared with intravenous therapies.

Long-Term Disease Management

Often used as an ongoing treatment to help control disease progression and maintain treatment response.

Evidence-Based Therapy

Imatinib has become an important treatment option in modern oncology due to its role in targeted cancer care.

Clinically Established Ingredient

Contains Imatinib Mesylate, a well-studied active ingredient used in multiple approved cancer treatment protocols.

Benefits of Imatib 400 mg Tablet

• Helps control the growth of abnormal cancer cells

• Supports long-term management of certain blood cancers

• Targets specific disease-causing proteins

• Available as an oral tablet for convenient administration

• May help reduce disease progression

• Used in several established treatment guidelines

• Provides targeted therapeutic action

• Suitable for specific cancers with identified genetic abnormalities

How to Take Imatib 400 mg Tablet

Take the tablet exactly as directed by your healthcare provider. The medicine is generally taken with food and a large glass of water to help reduce stomach irritation.

Swallow the tablet whole without crushing, breaking, or chewing unless specifically instructed by a healthcare professional. The timing and duration of treatment depend on the condition being treated and the patient's response to therapy.

Missing doses or stopping treatment without medical guidance may affect treatment outcomes.

Dosage Considerations

The prescribed dosage may vary depending on:

• Type of cancer or medical condition

• Disease stage and severity

• Body weight and age

• Response to treatment

• Liver and kidney function

• Other medications being used

Only a qualified healthcare professional can determine the appropriate dosage and treatment schedule.

Possible Side Effects

Like many prescription medications, Imatib 400 mg may cause side effects in some individuals.

Common Side Effects

• Nausea

• Vomiting

• Diarrhea

• Fatigue

• Muscle cramps

• Joint pain

• Swelling around the eyes

• Fluid retention

• Skin rash

• Headache

Less Common but Serious Side Effects

Medical attention may be required if symptoms such as the following occur:

• Severe swelling

• Unusual bleeding or bruising

• Persistent fever

• Shortness of breath

• Severe abdominal pain

• Signs of liver problems

• Significant weight gain due to fluid retention

Patients should promptly report any unusual symptoms to their healthcare provider.

Important Precautions

Before starting treatment, inform your doctor about your complete medical history, including:

Liver Disorders

The medication is processed by the liver and may require careful monitoring in patients with liver disease.

Heart Conditions

Individuals with cardiovascular disorders may require additional evaluation during treatment.

Kidney Problems

Patients with impaired kidney function may need dosage adjustments or closer monitoring.

Pregnancy and Breastfeeding

Imatib may not be suitable during pregnancy or breastfeeding. Discuss potential risks and benefits with your healthcare provider.

Drug Interactions

Certain medicines may affect how Imatib 400 mg works or increase the risk of side effects.

Potential interactions may occur with:

• Antifungal medications

• Certain antibiotics

• Blood thinners

• Seizure medications

• Immunosuppressants

• Some cholesterol-lowering medicines

• Herbal supplements such as St. John's Wort

Always provide a complete list of medications, supplements, and herbal products to your healthcare provider.

Monitoring During Treatment

Regular medical monitoring is often recommended while taking Imatib 400 mg. Your doctor may order:

• Complete blood count (CBC)

• Liver function tests

• Kidney function tests

• Imaging studies when appropriate

• Assessment of treatment response

Routine follow-up helps ensure the medication is working effectively while monitoring for potential adverse effects.

Storage Instructions

Store the tablets at room temperature in a dry place away from excessive heat and moisture.

Keep the medication in its original packaging and out of the reach of children and pets. Do not use the medicine after the expiration date printed on the package.

Who Should Avoid Imatib 400 mg Tablet?

This medication may not be appropriate for:

• Individuals with known hypersensitivity to Imatinib or its ingredients

• Patients advised against its use by their oncologist

• Individuals with certain severe medical conditions requiring alternative therapies

• Patients who are unable to undergo recommended treatment monitoring